XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Slugger who wrote (7276)	9/23/1998 2:03:00 AM
From: opalapril	Read Replies (2) of 17367

One last thought.... I suppose it's possible to tweak the P-3 design in retrospect by excluding from the overall population being counted and compared some discrete subset of patients for a compelling reason -- e.g., the hospital burned down in the middle of treatment, a treating doctor was exposed as a fraud with only an electrician's license, etc. But other than massaging the statistical sample in ways that exclude some patients from the overall population and therefore from the placebo and/or BPI groups, I don't under the FAQ. I don't get it all. Can anyone help out here?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next